TUCSON,
Ariz., May 23, 2022 /PRNewswire/ -- Accelerate
Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief
Executive Officer, Jack Phillips,
will present at the 42nd Annual William Blair Growth
Stock Conference on Thursday, June 7,
2022, at 10:00 AM Central
Time.
A live audiocast of the session will be accessible through the
company's investor relations website at ir.axdx.com. A replay
of the audiocast will be available for at least 30 days following
the conference.
About Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. is an in vitro diagnostics
company dedicated to providing solutions for the global challenges
of antimicrobial resistance and sepsis. The Accelerate Pheno®
system and Accelerate Arc™ system are designed to reduce the time
clinicians must wait to determine the most optimal antibiotic
therapy for bacteremic patients. These diagnostic systems are
designed to serve clinical laboratories with automated solutions to
expedite time to identification and antimicrobial susceptibility
test (AST) results directly from positive blood culture samples.
Multiple external studies have proven that Accelerate solutions
deliver results 1 to 2 days faster than existing methods, enabling
clinicians to optimize antibiotic selection and dosage specific to
the individual patient's infection, days earlier.
The "ACCELERATE DIAGNOSTICS" and "ACCELERATE PHENO" and
"ACCELERATE PHENOTEST" and "ACCELERATE ARC" and diamond shaped
logos and marks are trademarks or registered trademarks of
Accelerate Diagnostics, Inc. For more information about the
company, its products and technology, or recent publications,
visit axdx.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/accelerate-diagnostics-to-participate-in-42nd-annual-william-blair-growth-stock-conference-on-june-7-2022-301551670.html
SOURCE Accelerate Diagnostics, Inc.